|
|
|
| Take a tour of Nanoform's best-in-class nanodevelopment capabilities, setting new standards in innovation. Their highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. With 14 development lines for small molecules and 5 for large molecules, Nanoform offers unmatched scalability and precision. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers. Learn more. |
|
|
|
|
By Drug Delivery Leader: The Combination Products Handbook | This episode features a discussion on Chapter 8 from The Combination Products Handbook, focusing on post-market lifecycle management, with the book’s editor, Susan Neadle, and chapter co-author Khaudeja Bano. | |
|
|
Delivery Technologies Propelling GLP-1 Analogues | By Sampatkumarr Govind Donthula, MarketsandMarkets | Delve into the manufacturing and synthesizing technologies used to manufacture GLP-1 drugs, as well as the novel drug delivery technologies being used. |
|
|
|
| Is My Molecule Suitable For An Orally Disintegrating Tablet? | White Paper | By Susan Banbury, Ph.D., Adina Dîrlea, Charli Smardon, Catalent and Simon A. Lawton, MD, ALK, Catalent | Innovations in drug delivery formats are enabling more patient-centric treatments and helping to boost patient compliance. Learn about the advances being developed to expand ODT technology. |
|
|
| Characterizing Injection Factors For Self-Administered Delivery | Poster | By Wendy D Woodley, Didier R Morel, Ph.D., Diane E Sutter, Christopher A. Basciano, Ph.D., et al., BD Medical - Pharmaceutical Systems | The transition of intravenous in-clinic chronic disease therapies to large volume subcutaneous injections in alternate settings has created an evolving roster of new formulations and treatment options. |
|
|
| Primary Container Considerations For Cell Therapy Cryopreservation | Article | By Rui Li, Ph.D. and Krishnendu Khan, Ph.D., West Pharmaceutical Services, Inc. | Review different aspects of container selection from the perspective of cryopreservation that are may be overlooked but critical for the quality of cell therapy drug products. |
|
|
|
|
|
|
.png){kind=logo}
